Cargando…

Repurposing metabolic drugs for COVID-19

Detalles Bibliográficos
Autor principal: Bordon, Yvonne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013283/
https://www.ncbi.nlm.nih.gov/pubmed/36918668
http://dx.doi.org/10.1038/s41577-023-00862-0
_version_ 1784906781155131392
author Bordon, Yvonne
author_facet Bordon, Yvonne
author_sort Bordon, Yvonne
collection PubMed
description
format Online
Article
Text
id pubmed-10013283
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-100132832023-03-14 Repurposing metabolic drugs for COVID-19 Bordon, Yvonne Nat Rev Immunol In Brief Nature Publishing Group UK 2023-03-14 2023 /pmc/articles/PMC10013283/ /pubmed/36918668 http://dx.doi.org/10.1038/s41577-023-00862-0 Text en © Springer Nature Limited 2023 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle In Brief
Bordon, Yvonne
Repurposing metabolic drugs for COVID-19
title Repurposing metabolic drugs for COVID-19
title_full Repurposing metabolic drugs for COVID-19
title_fullStr Repurposing metabolic drugs for COVID-19
title_full_unstemmed Repurposing metabolic drugs for COVID-19
title_short Repurposing metabolic drugs for COVID-19
title_sort repurposing metabolic drugs for covid-19
topic In Brief
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013283/
https://www.ncbi.nlm.nih.gov/pubmed/36918668
http://dx.doi.org/10.1038/s41577-023-00862-0
work_keys_str_mv AT bordonyvonne repurposingmetabolicdrugsforcovid19